You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Grafton™ DBF inject is the first pre-loaded targeted bone graft delivery system that combines a highly osteoinductive1 DBM with a unique fiber technology and graft delivery syringe that can be injected into the surgical site.
DOWNLOAD THE BROCHUREThis all-in-one method features our patented* fiber flow technology and shows you how to efficiently hydrate and deliver our highly osteoinductive, 100% carrier-free DBM into your surgical site.
Grafton™ DBF Inject seamlessly integrates with Catalyft™ with bone graft flowing through the inserter and expanded into implant to completely fill the disc space.
Grafton™ DBF Inject is a precisely controlled bone graft delivery system that enables pre- and post-packing of graft material in the interbody space through integrated cannulas.
It can be used with certain Medtronic interbody devices, when hydrated with bone marrow aspirate (BMA) for spinal and orthopedic procedures.
Foot and Ankle
Extremities
Spinal Defect
Pelvis
Corpectomy
TLIF
Unique syringe design allows for precise delivery of our premium, highly osteoinductive DBM fiber, into traditionally difficult to access sites.
Grafton™ DBF Inject and its patented* fiber technology enables the first flowable carrier free Fiber DBM on the market today.
By eliminating the need for a bone funnel and tamp, Grafton™ DBF inject has the potential to reduce the number of steps needed to deliver bone graft and improve OR efficiencies.
Our unique syringe design allows for seamless hydration and delivery of our premium, Grafton™ DBF bone graft.
By eliminating the glycerol carrier, Grafton™ DBF Inject improves on the groundbreaking Grafton™ DBM technology by producing a more versatile osteoinductive bone graft.1
Grafton™ family of DBM's were the first fiber-based DBM's on the market. Our aseptically processed fibers have some of the highest osteoinductive scores1 of all the products we have tested† and this interconnected mesh of fibers enhances the osteoconductive potential of the product by providing a path for cellular infiltration.2
Download to view a summary of preclinical evidence for bone formation with Grafton™ DBF Inject.
4.3MB
DOWNLOAD WHITEPAPER Part Number |
Description |
Graft Volume |
---|---|---|
T50303INT |
Grafton™ DBF Inject |
3cc |
T50306INT |
Grafton™ DBF Inject |
6cc |
T50309INT |
Grafton™ DBF Inject |
9cc |
The integrated design of Catalyft™ PL Expandable Interbody System and Grafton™ DBF Inject streamlines the workflow and precisely delivers bone graft.
Grafton™ DBF Inject* boosts seamless fusion by flowing through the inserter and expanded implant to completely fill the disc space.
*Grafton DBF Inject can be used with the Catalyft™ PL Expandable Interbody System when hydrated with bone marrow aspirate (BMA) for spinal and orthopedic procedures.
Complete our contact form and your local sales representative will contact you.
Contact usReferenced path does not exist
*Third party brands are trademarks of their respective owners.
Patent number: US 10,660,685 B2.
Animal testing is not necessarily indicative of human clinical outcomes.
Data on file. Memo RAT OI Chart 09-01-2022 version 1. Based on internal testing in an athymic rat model. Histology scoring based on Edwards JT, Diegmann MH, Scarborough NL. Osteoinduction of human demineralized bone: characterization in a rat model. Clin Orthop Relat Res. 1998;357:219-228.
Martin, G.J. et al. Spine. 1999;24(7):637-645.
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at www.medtronic.eu